Profound Medical (Nasdaq:PROF) announced today that it sold shares of common stock worth proceeds of up to $40 million.

The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the efficacy of the device in eliminating cancer has yet to be established, ...

Closes $36 Million Registered Direct Offering. This article has been disseminated on behalf of Profound Medical Corp. and may include paid advertising. Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...

Scientists Discover Breakthrough Method to Target Treatment-Resistant CancersCancer’s greatest trick is evolving to beat our ...

Alpha Tau Medical Ltd ($DRTS) announced an update on their ongoing clinical study. Alpha Tau Medical Ltd (DRTS) has recently completed a clinical ...

That wide-ranging impact is why Popular Science chose the drops as the 2025 Health category winner. This year’s list also ...

Over the past year, the application of generative AI (genAI) in the Medical Instruments industry has moved from experimental ...